Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Antibiotic Treatment for Chlamydia Pneumonia in Multiple Sclerosis
NCT00043264Phase 2Completed
- Sponsor
- National Center for Research Resources
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of rifampicin, azithromycin in multiple sclerosis (MS), sponsored by National Center for Research Resources. Status: completed.
02
Drugs
rifampicinazithromycin
03
Conditions
multiple sclerosis (MS)
Beyond the preview
Go deeper on NCT00043264.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00043264.